EQRX insider filings

EQRx, Inc. — 50 most recent insider filings (SEC Forms 3/4/5) from EDGAR, normalized by FilingPulse. Latest filing: 2023-11-14. Screen EQRX transaction legs live →

Insider transaction summary — last 90 days

No insider filings (Forms 3/4/5) for EQRX between 2026-08-23 and 2026-11-21. The table below lists the most recent filings on record.

Recent insider filings — EQRx, Inc.

FiledFormInsiderReported transactionsSource
2023-11-144Casdin Eli — 10% ownerOther (J): 8,659,372 @ $0 · Other (J): 30,214,934 @ $0 · Other (J): 3,824,572 @ $0 · Other (J): 5,488,164 @ $0 · Other (J): 8,110,001 (derivative) @ $0 · Other (J): 3,472,300 (derivative) · +3 moreEDGAR
2023-11-094Ciarimboli Dina — General Counsel and SecretaryDisposition to issuer (D): 731,750 · Disposition to issuer (D): 156,750 (derivative) @ $0 · Disposition to issuer (D): 575,000 (derivative) @ $0 · Disposition to issuer (D): 43,172 (derivative)EDGAR
2023-11-094AH Equity Partners Bio II, L.L.C. — 10% owner
AH Bio Fund II, L.P. — 10% owner
AH Bio Fund II-B, L.P. — 10% owner
AH Equity Partners Bio III, L.L.C. — 10% owner
AH Bio Fund III, L.P. — 10% owner
AH Bio Fund III-B, L.P. — 10% owner
AH Bio Fund III-Q, L.P. — 10% owner
Code (U): 12,264 · Code (U): 17,438,465 · Code (U): 19,192,015 · Code (U): 11,433,677 · Code (U): 5,000,000 · Code (U): 2,401,418 (derivative) · +2 moreEDGAR
2023-11-094Nallicheri Melanie — Chief Executive Officer, DirectorOption exercise (M): 626,999 @ $2.21 · Disposition to issuer (D): 6,306,246 · Disposition to issuer (D): 3,851,147 · Option exercise (M): 626,999 (derivative) @ $0 · Disposition to issuer (D): 1,253,999 (derivative) @ $0 · Disposition to issuer (D): 1,900,000 (derivative) @ $0 · +2 moreEDGAR
2023-11-094Conde Jorge — DirectorDisposition to issuer (D): 17,438,465 · Disposition to issuer (D): 19,192,015 · Disposition to issuer (D): 11,433,677 · Disposition to issuer (D): 5,000,000 · Disposition to issuer (D): 2,401,418 (derivative) · Disposition to issuer (D): 2,642,897 (derivative) · +1 moreEDGAR
2023-11-094Horning Sandra — DirectorDisposition to issuer (D): 470,250 · Disposition to issuer (D): 313,500 (derivative) @ $0 · Disposition to issuer (D): 101,010 (derivative) @ $0 · Disposition to issuer (D): 107,929 (derivative)EDGAR
2023-11-094Abernethy Amy — DirectorDisposition to issuer (D): 200,000 · Disposition to issuer (D): 389,223 (derivative) @ $0EDGAR
2023-11-094Yeshwant Krishna — DirectorDisposition to issuer (D): 101,010 (derivative) @ $0EDGAR
2023-11-094MERKSAMER SAMUEL J. — DirectorDisposition to issuer (D): 101,010 (derivative) @ $0EDGAR
2023-11-094Borisy Alexis — Executive Chairman, DirectorDisposition to issuer (D): 18,810,000 · Disposition to issuer (D): 2,194,499 (derivative) @ $0 · Disposition to issuer (D): 2,892,491 (derivative)EDGAR
2023-11-094MEANWELL CLIVE — DirectorDisposition to issuer (D): 313,500 (derivative) @ $0 · Disposition to issuer (D): 101,010 (derivative) @ $0 · Disposition to issuer (D): 43,172 (derivative)EDGAR
2023-11-094BERNS PAUL L — DirectorDisposition to issuer (D): 627,000 · Disposition to issuer (D): 101,010 (derivative) @ $0 · Disposition to issuer (D): 86,344 (derivative)EDGAR
2023-11-094GIUSTI KATHRYN E — DirectorDisposition to issuer (D): 159,286 (derivative) @ $0 · Disposition to issuer (D): 101,010 (derivative) @ $0 · Disposition to issuer (D): 21,934 (derivative)EDGAR
2023-11-094AH Equity Partners LSV I, L.L.C. — 10% owner
Andreessen Horowitz LSV Fund I, L.P. — 10% owner
Andreessen Horowitz LSV Fund I-B, L.P. — 10% owner
Andreessen Horowitz LSV Fund I-Q, L.P. — 10% owner
AH Equity Partners LSV II, L.L.C. — 10% owner
Andreessen Horowitz LSV Fund II, L.P. — 10% owner
Andreessen Horowitz LSV Fund II-B, L.P. — 10% owner
Andreessen Horowitz LSV Fund II-Q, L.P. — 10% owner
Andreessen Marc L — 10% owner
HOROWITZ BENJAMIN A — 10% owner
Code (U): 12,264 · Code (U): 17,438,465 · Code (U): 19,192,015 · Code (U): 11,433,677 · Code (U): 5,000,000 · Code (U): 2,401,418 (derivative) · +2 moreEDGAR
2023-07-034Ciarimboli Dina — General Counsel and SecretaryGrant/award (A): 575,000 @ $0EDGAR
2023-02-224/AAbernethy Amy — DirectorGrant/award (A): 0 (derivative) @ $0EDGAR
2023-02-224/AAbernethy Amy — DirectorGrant/award (A): 389,223 (derivative) @ $0EDGAR
2023-01-054AH Equity Partners LSV I, L.L.C. — 10% owner
Andreessen Horowitz LSV Fund I, L.P. — 10% owner
Andreessen Horowitz LSV Fund I-B, L.P. — 10% owner
Andreessen Horowitz LSV Fund I-Q, L.P. — 10% owner
AH Equity Partners LSV II, L.L.C. — 10% owner
Andreessen Horowitz LSV Fund II, L.P. — 10% owner
Andreessen Horowitz LSV Fund II-B, L.P. — 10% owner
Andreessen Horowitz LSV Fund II-Q, L.P. — 10% owner
Andreessen Marc L — 10% owner
HOROWITZ BENJAMIN A — 10% owner
Grant/award (A): 12,577 (derivative) · Grant/award (A): 13,842 (derivative) · Grant/award (A): 8,246 (derivative)EDGAR
2023-01-044Ciarimboli Dina — General Counsel and SecretaryGrant/award (A): 226 (derivative)EDGAR
2023-01-044Rubin Jami — Chief Financial OfficerGrant/award (A): 1,585 (derivative)EDGAR
2023-01-044AH Equity Partners Bio II, L.L.C. — 10% owner
AH Bio Fund II, L.P. — 10% owner
AH Bio Fund II-B, L.P. — 10% owner
AH Equity Partners Bio III, L.L.C. — 10% owner
AH Bio Fund III, L.P. — 10% owner
AH Bio Fund III-B, L.P. — 10% owner
AH Bio Fund III-Q, L.P. — 10% owner
Grant/award (A): 12,577 (derivative) · Grant/award (A): 13,842 (derivative) · Grant/award (A): 8,246 (derivative)EDGAR
2023-01-044Nallicheri Melanie — Chief Executive Officer, DirectorGrant/award (A): 5,453 (derivative) · Grant/award (A): 2,777 (derivative)EDGAR
2023-01-044Conde Jorge — DirectorGrant/award (A): 12,577 (derivative) · Grant/award (A): 13,842 (derivative) · Grant/award (A): 8,246 (derivative)EDGAR
2023-01-044Horning Sandra — DirectorGrant/award (A): 565 (derivative)EDGAR
2023-01-044Casdin Eli — 10% ownerGrant/award (A): 18,184 (derivative) · Grant/award (A): 2,758 (derivative) · Grant/award (A): 3,959 (derivative)EDGAR
2023-01-044Hedrick Eric — Chief Physician ExecutiveGrant/award (A): 543 (derivative)EDGAR
2023-01-044Borisy Alexis — Executive Chairman, DirectorGrant/award (A): 15,148 (derivative)EDGAR
2023-01-044MEANWELL CLIVE — DirectorGrant/award (A): 226 (derivative)EDGAR
2023-01-044BERNS PAUL L — DirectorGrant/award (A): 453 (derivative)EDGAR
2023-01-044GIUSTI KATHRYN E — DirectorGrant/award (A): 114 (derivative)EDGAR
2022-10-044Horning Sandra — DirectorGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-10-044Abernethy Amy — DirectorGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-10-044Yeshwant Krishna — DirectorGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-10-044Casdin Eli — Director, 10% ownerGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-10-044MERKSAMER SAMUEL J. — DirectorGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-10-044MEANWELL CLIVE — DirectorGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-10-044BERNS PAUL L — DirectorGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-10-044GIUSTI KATHRYN E — DirectorGrant/award (A): 101,010 (derivative) @ $0EDGAR
2022-03-014Ciarimboli Dina — General Counsel and SecretaryGrant/award (A): 575,000 (derivative) @ $0EDGAR
2022-03-014Rubin Jami — Chief Financial OfficerGrant/award (A): 515,601 (derivative) @ $0EDGAR
2022-03-014Nallicheri Melanie — Chief Executive Officer, DirectorGrant/award (A): 1,900,000 (derivative) @ $0EDGAR
2022-03-014Abernethy Amy — DirectorGrant/award (A): 449,644 (derivative) @ $0EDGAR
2022-03-014Hedrick Eric — Chief Physician ExecutiveGrant/award (A): 505,051 (derivative) @ $0EDGAR
2021-12-234/ACasdin Eli — Director, 10% ownerOption exercise (M): 8,659,372 · Other (J): 8,659,372 · Other (J): 8,659,372 · Grant/award (A): 25,214,934 · Grant/award (A): 5,000,000 @ $10 · Grant/award (A): 3,824,572 · +7 moreEDGAR
2021-12-214Abernethy Amy — DirectorOption exercise (M): 200,000 · Other (J): 200,000 · Other (J): 200,000 · Option exercise (M): 200,000 (derivative)EDGAR
2021-12-214Casdin Eli — DirectorOther (J): 8,659,372 @ $0 · Grant/award (A): 34,527,671 @ $0 · Grant/award (A): 5,000,000 @ $10 · Other (J): 4,840,628 (derivative) @ $0 · Other (J): 8,659,372 (derivative) @ $0 · Grant/award (A): 8,110,001 (derivative)EDGAR
2021-12-214Hedrick Eric — Chief Physician ExecutiveGrant/award (A): 627,000 · Grant/award (A): 125,399 (derivative) @ $0 · Grant/award (A): 103,069 (derivative)EDGAR
2021-12-214Borisy Alexis — DirectorGrant/award (A): 18,810,000 · Grant/award (A): 2,194,499 (derivative) @ $0 · Grant/award (A): 2,877,343 (derivative)EDGAR
2021-12-214BERNS PAUL L — DirectorGrant/award (A): 627,000 · Grant/award (A): 85,891 (derivative)EDGAR
2021-12-214GIUSTI KATHRYN E — DirectorGrant/award (A): 159,286 (derivative) @ $0 · Grant/award (A): 21,820 (derivative)EDGAR

Recent 8-K events — EQRx, Inc.

Items classified from EDGAR index headers. Browse recent 8-K filings market-wide, by item code →

FiledFormItems reportedSource
2023-11-098-K2.01 — Completion of Acquisition or Disposition of Assets
3.01 — Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
3.03 — Material Modification to Rights of Security Holders
5.01 — Changes in Control of Registrant
5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers
5.03 — Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
5.07 — Submission of Matters to a Vote of Security Holders
9.01 — Financial Statements and Exhibits
EDGAR
2023-11-018-K8.01 — Other EventsEDGAR
2023-08-038-K1.02 — Termination of a Material Definitive Agreement
?
EDGAR
2023-08-018-K1.01 — Entry into a Material Definitive Agreement
7.01 — Regulation FD Disclosure
8.01 — Other Events
9.01 — Financial Statements and Exhibits
EDGAR
2023-05-088-K1.02 — Termination of a Material Definitive Agreement
2.02 — Results of Operations and Financial Condition
?
9.01 — Financial Statements and Exhibits
EDGAR
2023-03-138-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2023-02-238-K2.02 — Results of Operations and Financial Condition
?
9.01 — Financial Statements and Exhibits
EDGAR
2023-01-118-K2.02 — Results of Operations and Financial Condition
7.01 — Regulation FD Disclosure
9.01 — Financial Statements and Exhibits
EDGAR
2022-11-258-K5.02 — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain OfficersEDGAR
2022-11-108-K2.02 — Results of Operations and Financial Condition
9.01 — Financial Statements and Exhibits
EDGAR
Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?ticker=EQRX returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new ones to you in seconds. Get a free API key → · API docs